SEC Form 4 · accession 0000882104-17-000033
PDL BIOPHARMA, INC. · PDLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter S Garcia
Officer — Vice President, CFO
Period of report
Mar 24, 2017
Accepted (ET)
Mar 27, 2017 · 5:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882104
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Mar 24, 2017 | P | 4,650 | $1.974 | A | 452,492 | D | |
| Common stock | Mar 24, 2017 | P | 350 | $1.975 | A | 452,842 | D | |
| Common stock | Mar 24, 2017 | P | 10,000 | $1.9757 | A | 462,842 | D | |
| Common stock | Mar 24, 2017 | P | 5,000 | $1.9768 | A | 467,842 | D | |
| Common stock | Mar 24, 2017 | P | 5,000 | $1.978 | A | 472,842 | D |
Table II — derivative securities
No Table II lines on this filing.